Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

(2014) E. Camenzind et al.   EUROPEAN HEART JOURNAL

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

(2013) Clemens von Birgelen et al.   LANCET

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

(2012) G. G. Stefanini et al.   EUROPEAN HEART JOURNAL

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

(2012) Edoardo Camenzind et al.   LANCET

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

(2010) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

(2010) Patrick W. Serruys et al.   NEW ENGLAND JOURNAL OF MEDICINE

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

(2010) Pascal Vranckx et al.   EuroIntervention

Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation

(2009) Edoardo Camenzind et al.   AMERICAN HEART JOURNAL

Stent Thrombosis in Sweden

(2009) Bo Lagerqvist et al.   Circulation-Cardiovascular Interventions

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent

(2009) Eric L. Eisenstein et al.   JACC-Cardiovascular Interventions

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

(2008) Michael Joner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

(2008) Stephan Windecker et al.   LANCET